Gene: PPL

5493
-
periplakin
protein-coding
16p13.3
Ensembl:ENSG00000118898 MIM:602871 Vega:OTTHUMG00000129528 UniprotKB:O60437
NC_000016.10
PubMed
ND
2   
NA (AD)  NA (ND)   (Frontal_Cortex)
5.530e-1 (AD)  7.930e-1 (ND)

DNA Methylation

There is no related methylation information for this gene.

Gene Expression in Different Tissues

Temporal and Spatial Expressions (BrainSpan)

Footnote:
SC: sub-cortical regions; SM: sensory-motor regions; FC: frontal cortex; and TP: temporal-parietal cortex
ST1: fetal (13 - 26 postconception weeks), ST2: early infancy to late childhood (4 months to 11 years), and ST3: adolescence to adulthood (13 - 23 years)
The bar shown representes average value of the expressions.

Top Co-expressed Genes in Brain-Frontal Cortex (BA9) (GTEx v7)

Top 10 positively co-expressed genes

Gene Symbol Pearson Correlation Coefficient
HECW10.952
PTPRT0.951
PTPN30.943
ZNF385B0.94
STXBP5L0.939
SV2B0.933
TNFAIP8L10.931
LRRC40.93
KCNC10.93
NCALD0.929

Top 10 negatively co-expressed genes

Gene Symbol Pearson Correlation Coefficient
HEY2-0.623
REST-0.621
YES1-0.62
RAB13-0.612
WWTR1-0.597
RAI14-0.575
TMEM176A-0.574
LRAT-0.572
RNF135-0.57
GNG12-0.569

Drugs/Compounds

    There is no DrugBank record for this gene !

ID Drug Name Action PubMed
C0264861,2,5,6-dibenzanthracene"1,2,5,6-dibenzanthracene results in increased expression of PPL mRNA"26377693
C0005915411-cyclopropyl-4-(4-((5-methyl-3-(3-(4-(trifluoromethoxy)phenyl)-1,2,4-oxadiazol-5-yl)-1H-pyrazol-1-yl)methyl)pyridin-2-yl)piperazine"1-cyclopropyl-4-(4-((5-methyl-3-(3-(4-(trifluoromethoxy)phenyl)-1,2,4-oxadiazol-5-yl)-1H-pyrazol-1-yl)methyl)pyridin-2-yl)piperazine inhibits the reaction [Oxygen deficiency results in increased expression of PPL mRNA]"24403227
C5486512-(1'H-indolo-3'-carbonyl)thiazole-4-carboxylic acid methyl ester2-(1'H-indolo-3'-carbonyl)thiazole-4-carboxylic acid methyl ester results in decreased expression of PPL mRNA19933214
C0291412,2,5,7,8-pentamethyl-1-hydroxychroman"2,2,5,7,8-pentamethyl-1-hydroxychroman results in increased expression of PPL mRNA"21920950
C0294972,3-bis(3'-hydroxybenzyl)butyrolactone"[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of PPL mRNA"19167446
C0164032,4-dinitrotoluene"2,4-dinitrotoluene affects the expression of PPL mRNA"21346803
C0235142,6-dinitrotoluene"2,6-dinitrotoluene results in increased expression of PPL mRNA"20406850
C0065512-amino-2-methyl-1-propanol2-amino-2-methyl-1-propanol results in decreased expression of PPL mRNA25088246
C0230353,4,5,3',4'-pentachlorobiphenyl"3,4,5,3',4'-pentachlorobiphenyl results in decreased expression of PPL mRNA"19692669
C4591794-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide"[NOG protein co-treated with entinostat co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PPL mRNA"27188386
C4591794-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide"[NOG protein co-treated with mercuric bromide co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PPL mRNA"27188386
C4591794-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide"[NOG protein co-treated with panobinostat co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PPL mRNA"27188386
C4591794-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide"[NOG protein co-treated with Phenylmercuric Acetate co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PPL mRNA"27188386
C4591794-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide"[NOG protein co-treated with Valproic Acid co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PPL mRNA"27188386
C0293704-toluidine4-toluidine results in increased expression of PPL mRNA27638505
C516138(6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine"[NOG protein co-treated with entinostat co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PPL mRNA"27188386
C516138(6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine"[NOG protein co-treated with mercuric bromide co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PPL mRNA"27188386
C516138(6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine"[NOG protein co-treated with panobinostat co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PPL mRNA"27188386
C516138(6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine"[NOG protein co-treated with Phenylmercuric Acetate co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PPL mRNA"27188386
C516138(6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine"[NOG protein co-treated with Valproic Acid co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PPL mRNA"27188386
D000082AcetaminophenAcetaminophen results in decreased expression of PPL mRNA21420995
D000082AcetaminophenAcetaminophen results in increased expression of PPL mRNA25704631
D000082AcetaminophenAcetaminophen affects the expression of PPL mRNA17562736
D000968Antimycin AAntimycin A results in decreased expression of PPL mRNA19304788
D018501Antirheumatic AgentsAntirheumatic Agents results in increased expression of PPL mRNA24449571
D017636Asbestos, Amphibole"Asbestos, Amphibole results in decreased expression of PPL mRNA"20831825
D017638Asbestos, Crocidolite"Asbestos, Crocidolite results in decreased expression of PPL mRNA"20831825
D001379AzathioprineAzathioprine results in increased expression of PPL mRNA22623647
C547126AZM551248AZM551248 results in decreased expression of PPL mRNA22323515
C022921benzo(k)fluoranthenebenzo(k)fluoranthene results in increased expression of PPL mRNA26377693
D001564Benzo(a)pyreneBenzo(a)pyrene results in increased expression of PPL mRNA26001963
D001564Benzo(a)pyreneBenzo(a)pyrene results in decreased expression of PPL mRNA20106945
D001564Benzo(a)pyreneBenzo(a)pyrene promotes the reaction [AHR protein binds to PPL promoter]19654925
C072553benzyloxycarbonylleucyl-leucyl-leucine aldehydebenzyloxycarbonylleucyl-leucyl-leucine aldehyde results in increased expression of PPL mRNA20061341
D004958EstradiolEstradiol affects the expression of PPL mRNA23557687
C006780bisphenol Abisphenol A results in increased expression of PPL mRNA25594700
D020122tert-Butylhydroperoxidetert-Butylhydroperoxide results in decreased expression of PPL mRNA15336504
D020122tert-Butylhydroperoxidetert-Butylhydroperoxide results in increased expression of PPL mRNA15003993
C584509C646 compoundC646 compound results in increased expression of PPL mRNA26191083
D002220CarbamazepineCarbamazepine affects the expression of PPL mRNA25979313
D002251Carbon TetrachlorideCarbon Tetrachloride results in increased expression of PPL mRNA27339419
D002794Choline[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of PPL mRNA20938992
D003375Coumestrol"[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of PPL mRNA"19167446
D003375Coumestrol[Coumestrol co-treated with resveratrol] results in decreased expression of PPL mRNA19167446
D003375CoumestrolCoumestrol results in decreased expression of PPL mRNA19167446
D003471CuprizoneCuprizone results in decreased expression of PPL mRNA27523638
D016572CyclosporineCyclosporine affects the expression of PPL mRNA20106945
D016572CyclosporineCyclosporine results in increased expression of PPL mRNA21632981|2556210
D016572CyclosporineCyclosporine results in increased expression of PPL mRNA21865292
D003907DexamethasoneDexamethasone inhibits the reaction [RX3 gene mutant form affects the expression of PPL mRNA]27941970
D003907DexamethasoneDexamethasone results in increased expression of PPL mRNA22733784
D002945CisplatinCisplatin results in decreased expression of PPL mRNA27392435
D002945CisplatinCisplatin results in increased expression of PPL mRNA22023808
C036042dicyclohexyl phthalatedicyclohexyl phthalate affects the expression of PPL mRNA26924002
D004041Dietary FatsDietary Fats results in increased expression of PPL mRNA22609946
D004051Diethylhexyl PhthalateDiethylhexyl Phthalate results in increased expression of PPL mRNA19850644
D004051Diethylhexyl PhthalatePPARA protein promotes the reaction [Diethylhexyl Phthalate results in increased expression of PPL mRNA]19850644
D004052DiethylnitrosamineDiethylnitrosamine results in increased expression of PPL mRNA24535843
D002117CalcitriolCalcitriol results in increased expression of PPL mRNA21592394|2648566
D002117Calcitriol[Testosterone co-treated with Calcitriol] results in increased expression of PPL mRNA21592394
D004237DiuronDiuron results in decreased expression of PPL mRNA21551480
C118739entinostatentinostat results in increased expression of PPL mRNA26272509
C118739entinostat"[NOG protein co-treated with entinostat co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PPL mRNA"27188386
D004997Ethinyl EstradiolEthinyl Estradiol results in increased expression of PPL mRNA17557909
D005020Ethyl MethanesulfonateEthyl Methanesulfonate results in increased expression of PPL mRNA23649840
D005492Folic Acid[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of PPL mRNA20938992
D005557FormaldehydeFormaldehyde results in increased expression of PPL mRNA23649840|2893796
C069837fullerene C60fullerene C60 results in decreased expression of PPL mRNA19167457
C039281furanfuran results in increased expression of PPL mRNA24183702
C039281furanfuran results in decreased methylation of PPL gene27387713
C039281furanfuran results in increased expression of PPL mRNA25539665|2738771
D019833GenisteinESR2 promotes the reaction [Genistein results in decreased expression of PPL protein]20884965
D019833GenisteinGenistein results in decreased expression of PPL protein20884965
D006118GriseofulvinGriseofulvin affects the expression of PPL mRNA12735108
D017313FenretinideFenretinide results in decreased expression of PPL mRNA28973697
C492448ICG 001ICG 001 results in decreased expression of PPL mRNA26191083
C561695(+)-JQ1 compound(+)-JQ1 compound results in increased expression of PPL mRNA26752646
C482199lipopolysaccharide, E coli O55-B5"lipopolysaccharide, E coli O55-B5 results in increased expression of PPL mRNA"24972896
C042720mercuric bromidemercuric bromide results in increased expression of PPL mRNA26272509
C042720mercuric bromide"[NOG protein co-treated with mercuric bromide co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PPL mRNA"27188386
D008713MethimazoleMethimazole results in increased expression of PPL mRNA22504374
D008715Methionine[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of PPL mRNA20938992
D008741Methyl MethanesulfonateMethyl Methanesulfonate results in increased expression of PPL mRNA23649840
D018817N-Methyl-3,4-methylenedioxyamphetamine"N-Methyl-3,4-methylenedioxyamphetamine results in decreased expression of PPL mRNA"20188158
D0156551-Methyl-4-phenylpyridinium1-Methyl-4-phenylpyridinium results in increased expression of PPL mRNA24810058
C517284monomethyl phthalatemonomethyl phthalate affects the expression of PPL mRNA26924002
C554954N-((3S)-1-azabicyclo(2.2.2)oct-3-yl)-1H-indazole-3-carboxamide hydrochlorideN-((3S)-1-azabicyclo(2.2.2)oct-3-yl)-1H-indazole-3-carboxamide hydrochloride results in increased expression of PPL mRNA28174063
D037742Nanotubes, Carbon"Nanotubes, Carbon affects the expression of PPL mRNA"25554681
D037742Nanotubes, Carbon"Nanotubes, Carbon analog results in increased expression of PPL mRNA"25554681
C028007nickel monoxidenickel monoxide results in decreased expression of PPL mRNA19167457
D010100Oxygen"1-cyclopropyl-4-(4-((5-methyl-3-(3-(4-(trifluoromethoxy)phenyl)-1,2,4-oxadiazol-5-yl)-1H-pyrazol-1-yl)methyl)pyridin-2-yl)piperazine inhibits the reaction [Oxygen deficiency results in increased expression of PPL mRNA]"24403227
D010100OxygenOxygen deficiency results in increased expression of PPL mRNA24403227|2651600
C496932panobinostat"[NOG protein co-treated with panobinostat co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PPL mRNA"27188386
C496932panobinostatpanobinostat results in increased expression of PPL mRNA26272509
D010433Pentylenetetrazole[Pentylenetetrazole co-treated with Vigabatrin] affects the expression of PPL mRNA21503142
D010634PhenobarbitalNR1I3 protein affects the reaction [Phenobarbital results in increased expression of PPL mRNA]19482888
D010634PhenobarbitalPhenobarbital results in increased expression of PPL mRNA19482888
D010662Phenylmercuric Acetate"[NOG protein co-treated with Phenylmercuric Acetate co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PPL mRNA"27188386
D010662Phenylmercuric AcetatePhenylmercuric Acetate results in increased expression of PPL mRNA26272509
C006253pirinixic acid[pirinixic acid binds to and results in increased activity of PPARA protein] which results in decreased expression of PPL mRNA19710929
D010936Plant ExtractsPlant Extracts results in decreased expression of PPL mRNA23557933
D011285Pregnenolone CarbonitrilePregnenolone Carbonitrile results in decreased expression of PPL mRNA28903501
D011374ProgesteroneProgesterone results in increased expression of PPL mRNA18070364
D011441PropylthiouracilPropylthiouracil results in decreased expression of PPL mRNA24780913
D011441PropylthiouracilPropylthiouracil results in increased expression of PPL mRNA22504374
C059514resveratrol[Coumestrol co-treated with resveratrol] results in decreased expression of PPL mRNA19167446
D012402RotenoneRotenone results in decreased expression of PPL mRNA19304788
C513635S-2-pentyl-4-pentynoic hydroxamic acidS-2-pentyl-4-pentynoic hydroxamic acid results in increased expression of PPL mRNA21427059
D012822Silicon DioxideSilicon Dioxide analog results in decreased expression of PPL mRNA25895662
D020123SirolimusSirolimus results in increased expression of PPL mRNA21865292
D012906SmokeSmoke results in decreased expression of PPL mRNA21095227
C009277sodium arsenatesodium arsenate results in decreased expression of PPL mRNA23922661
C017947sodium arsenitesodium arsenite results in decreased methylation of PPL gene24570342
C017947sodium arsenitesodium arsenite results in increased expression of PPL mRNA24570342
D012999SomanSoman results in decreased expression of PPL mRNA19281266
D053260SootSoot results in increased expression of PPL mRNA26551751
D016559TacrolimusTacrolimus results in increased expression of PPL mRNA21865292
D013629TamoxifenTamoxifen results in decreased expression of PPL mRNA25123088
D013739Testosterone[Testosterone co-treated with Calcitriol] results in increased expression of PPL mRNA21592394
D013739TestosteroneTestosterone results in increased expression of PPL mRNA21592394
D013739TestosteroneTestosterone results in decreased expression of PPL mRNA19693291
D013749TetrachlorodibenzodioxinTetrachlorodibenzodioxin affects the expression of PPL mRNA22298810
D013749TetrachlorodibenzodioxinTetrachlorodibenzodioxin results in decreased expression of PPL mRNA20106945
D013749TetrachlorodibenzodioxinTetrachlorodibenzodioxin results in increased expression of PPL mRNA23152189
D013749TetrachlorodibenzodioxinTetrachlorodibenzodioxin affects the expression of PPL mRNA21570461
D013749TetrachlorodibenzodioxinTetrachlorodibenzodioxin results in decreased expression of PPL mRNA19933214
D013749TetrachlorodibenzodioxinTetrachlorodibenzodioxin results in increased expression of PPL mRNA17035482|2892240
D013853ThioacetamideThioacetamide results in increased expression of PPL mRNA23411599
C009495titanium dioxidetitanium dioxide results in decreased expression of PPL mRNA23557971
D014028Tobacco Smoke PollutionTobacco Smoke Pollution results in decreased expression of PPL mRNA28065790
D014241TrichloroethyleneTrichloroethylene results in decreased expression of PPL mRNA26745549
C012589trichostatin Atrichostatin A results in decreased expression of PPL mRNA15901671
C012589trichostatin Atrichostatin A results in increased expression of PPL mRNA24935251
C015559trimellitic anhydridetrimellitic anhydride results in decreased expression of PPL mRNA19042947
C016805tris(1,3-dichloro-2-propyl)phosphate"tris(1,3-dichloro-2-propyl)phosphate results in increased expression of PPL mRNA"26179874
C057693troglitazonetroglitazone results in increased expression of PPL mRNA28973697
D014635Valproic AcidValproic Acid results in decreased expression of PPL mRNA15901671
D014635Valproic Acid"[NOG protein co-treated with Valproic Acid co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PPL mRNA"27188386
D014635Valproic AcidValproic Acid results in increased expression of PPL mRNA23179753|2438349
D014635Valproic AcidValproic Acid affects the expression of PPL mRNA17292431
D014635Valproic AcidValproic Acid results in increased expression of PPL mRNA21427059
D020888Vigabatrin[Pentylenetetrazole co-treated with Vigabatrin] affects the expression of PPL mRNA21503142
D014810Vitamin EVitamin E results in decreased expression of PPL mRNA19244175
C088658zoledronic acidzoledronic acid results in decreased expression of PPL mRNA24714768

GO/Pathway

GO ID GO Term Qualifier Evidence PubMed
GO:0005198structural molecule activity-IBA21873635  
GO:0005200structural constituent of cytoskeleton-TAS9521878  
GO:0005515protein binding-IPI12244133  18624398  22841549  25416956  25637025  
GO:0045296cadherin binding-HDA25468996  
GO:0045296cadherin binding-IBA21873635  
GO ID GO Term Qualifier Evidence PubMed
GO:0007010cytoskeleton organization-IEA-  
GO:0009612response to mechanical stimulus-IEP19211270  
GO:0042060wound healing-IBA21873635  
GO:0045104intermediate filament cytoskeleton organization-IBA21873635  
GO:0070268cornification-TAS-  
GO ID GO Term Qualifier Evidence PubMed
GO:0001533cornified envelope-TAS-  
GO:0005634nucleus-IEA-  
GO:0005737cytoplasm-IBA21873635  
GO:0005739mitochondrion-IEA-  
GO:0005829cytosol-TAS-  
GO:0005856cytoskeleton-IEA-  
GO:0005882intermediate filamentCOLOCALIZES_WITHIBA21873635  
GO:0016020membrane-IBA21873635  
GO:0030057desmosome-IEA-  
GO:0070062extracellular exosome-HDA19056867  19199708  
KEGG ID KEGG Term
Reactome ID Reactome Term Evidence
R-HSA-1266738Developmental BiologyTAS
R-HSA-1280218Adaptive Immune SystemTAS
R-HSA-168256Immune SystemTAS
R-HSA-6805567KeratinizationTAS
R-HSA-6809371Formation of the cornified envelopeTAS
R-HSA-8851680Butyrophilin (BTN) family interactionsTAS

Interactions (STRING v10.5, Interaction Score >= 0.400)

Publications (Co-occurrence of gene symbol strings and ANCO-Dependence terms)

PMID Title (Year) Author Journal
27768609Long-chain omega-6 plasma phospholipid polyunsaturated fatty acids and association with colon adenomas in adult men: a cross-sectional study. (2017 Nov)Pickens CAEur J Cancer Prev
26721667Altered Saturated and Monounsaturated Plasma Phospholipid Fatty Acid Profiles in Adult Males with Colon Adenomas. (2016 Mar)Pickens CACancer Epidemiol Biomarkers Prev